|
December 14, 2006: Baxter Receives Conditional Approval for U.S. COLLEAGUE Infusion Pump Corrective Action Plan and Submits Updated 510(k) Pre-Market Notification
December 11, 2006: Baxter Announces Therapeutic Development Program for First Blood-Free Recombinant Von Willebrand Factor
December 11, 2006: Baxter Presents Preclinical Studies of Experimental Longer-Acting Hemophilia A Therapy
December 08, 2006: Baxter to Withdraw NYSE ARCA Listing, Retains New York Stock Exchange Listing
November 28, 2006: Baxter Declares Annual Dividend and Announces Modifications to Dividend Policy
November 21, 2006: Baxter Receives Preparedness Contract From Austrian Ministry of Health For Pandemic Influenza Vaccine
November 20, 2006: Baxter Inducts Donors from 13 Blood Centers Across the Country Into Donation Hall of Fame
November 14, 2006: Baxter Announces Renal Discoveries Grant Winners
November 14, 2006: Baiyunshan and Baxter Announce Plans to Form Parenteral Nutrition Joint Venture in China
October 23, 2006: Baxter Receives Marketing Approval for ADVATE® in Japan
October 19, 2006: Baxter Reports Strong Earnings for the Third Quarter with EPS of $0.57 Per Share
October 16, 2006: Baxter Commemorates 75 Years of Innovation and Leadership in Healthcare
October 12, 2006: Baxter Highlights Social, Economic and Environmental Performance in Seventh Annual Sustainability Report
October 11, 2006: Baxter Announces Launch of BAXJECT II Needle-Less Transfer Device for ADVATE
October 04, 2006: Baxter Announces Safety and Immunogenicity Results from Phase I/II Clinical Trial of Cell-Based Candidate H5N1 Pandemic Vaccine
October 03, 2006: Baxter's Board Adopts Majority Vote Standard for Election of Directors
October 03, 2006: Baxter Announces Sale of Transfusion Therapies Business to Texas Pacific Group
September 29, 2006: National Hemophilia Foundation Grants 2006 Awards Under Baxter-Sponsored NHF Clinical Fellowship Program
September 29, 2006: Baxter Announces the Winners of Camp Superfly II Program for the Bleeding and Clotting Disorders Community
September 18, 2006: AABB and Baxter Sponsor Second Annual Blood Collectors Week
September 14, 2006: Baxter Names Carlos Alonso President of Latin American Region
September 07, 2006: Baxter Names Peter Nicklin Corporate Vice President and President, Baxter Europe
August 14, 2006: Genetics Alliance Recognizes Baxter for Screening Program to Identify Patients At Risk for Hereditary Emphysema
August 02, 2006: Baxter Receives Health Canada Approval for ADVATE
August 01, 2006: FDA Approves ADEPT® Adhesion Reduction Solution [4% Icodextrin Solution]
July 20, 2006: Baxter's Second Quarter Sales and Earnings Exceed Expectations
July 06, 2006: Matching Grant Made to Benefit Hurricane-Affected Health Organizations
July 05, 2006: Baxter Initiates Clinical Study With Cell-Based Candidate H5N1 Pandemic Vaccine
June 29, 2006: Baxter and FDA Reach Agreement on Next Steps for U.S. Infusion Pumps
June 27, 2006: Halozyme and Baxter Announce Availability of Hylenex for Subcutaneous Delivery of Medications and Fluids
June 20, 2006: Baxter Supports Prioritisation of Primary Immunodeficiencies as EU Public Health Priority
June 15, 2006: Baxter Receives Tentative FDA Approvals for Ondansetron Injection in Vials and Premix Containers
June 06, 2006: The Baxter International Foundation Awards Grants in Five Countries to Improve Access to Healthcare
May 24, 2006: Baxter is Recognized by the Association of Hemophilia Clinic Directors of Canada
May 23, 2006: Baxter Announces Winners of "Picture Your Tomorrow, Today" Global Photo Contest
May 18, 2006: Baxter and Jerini Advance Program to Develop Non-Intravenous Hemophilia Therapy
May 17, 2006: U.S. EPA Recognizes Baxter as a Recipient of 2006 Climate Protection Award
May 17, 2006: Baxter Appoints John Greisch President of International; Treasurer Robert Davis Succeeds Greisch as CFO
May 17, 2006: Baxter Collaborates With Gambro BCT on 7-Day Platelet Study to Speed Adoption
May 15, 2006: Baxter's Board Appoints New Corporate Officers, Including Heads of Regional Businesses in Latin America and Asia Pacific
May 09, 2005: Baxter Highlights Significant Financial Progress and Recent Investments at Annual Meeting of Shareholders
May 09, 2005: Baxter Receives FDA Approval for Ultra-High Dosage Strength of ADVATE for Hemophilia A
May 04, 2006: Baxter to Participate in Development of Cell-Based Vaccines for U.S. Department of Health and Human Services
April 24, 2006: Linda H. Aiken, PhD, Selected As The Inaugural Recipient of the William B. Graham Prize For Health Services Research
April 20, 2006: Baxter Reports First Quarter Earnings Per Diluted Share of $0.43, An Increase of 19 Percent
April 18, 2006: Baxter Announces New AVIVA Line of Intravenous Solutions
April 13, 2006: Baxter Highlights Work of World Federation of Hemophilia in Addressing Global Disparities in Hemophilia Care
April 10, 2006: Baxter Executive Named Working Mother of the Year
April 05, 2006: Baxter Launches Enhanced Grant Program To Promote Scientific Advancement and Training In Treatment of Kidney Disease
April 04, 2006: More Than 10,000 People Screened For AAT Deficiency Through Baxter-Sponsored Effort
April 03, 2006: Baxter Names Jeanne K. Mason Corporate Vice President, Human Resources
March 30, 2006: Baxter Names Karenann Terrell Chief Information Officer
March 30, 2006: Baxter Kicks Off Second Annual CAMP SUPERFLY Program For The Bleeding And Clotting Disorders Community
March 29, 2006: Baxter Names Cheryl White Corporate V.P. Quality
March 23, 2006: Baxter Announces Launch of Authorized Generic Azithromycin for Injection
March 22, 2006: Baxter Announces Investment of $60 Million To Expand Manufacturing Capacity In China
March 16, 2006: International Survey of Practices in Hemophilia A Treatment Published in Haemophilia
March 07, 2006: Baxter Commences First-Of-Its-Kind, Phase II Adult Stem Cell Trial in U.S. In Patients With Severe Coronary Artery Disease
March 06, 2006: Baxter Study Verifies Inactivation of Influenza H5N1 Virus During Manufacture of its Plasma-Derived Therapies
March 02, 2006: Baxter And Its Foundation Contribute More Than $35 Million In 2005 To Communities in Need
February 24, 2006: Baxter Receives Contract From National Health Service in United Kingdom to Produce Stockpile of H5N1 Flu Vaccine
February 20, 2006: Baxter Supports Earthquake Victims in India and Pakistan Through Donation of Meningitis Vaccines, Foundation Grant and Employee Matching Gifts
February 16, 2006: Baxter Issues Shares to Settle Equity Units
February 15, 2006: Baxter's Board Authorizes $1.5 Billion Share Repurchase Program
February 13, 2006: Cerus Obtains Exclusive Rights to INTERCEPT Blood System from Baxter
February 08, 2006: Halozyme Therapeutics and Baxter Release Results from the INFUSE-LR Study
February 02, 2006: Baxter Announces Classification of Letter to Customers Regarding COLLEAGUE Infusion Pumps
January 31, 2006: Baxter's ADVATE Achieves One Billion Unit Milestone
January 26, 2006: Baxter Reports Financial Results for the Fourth Quarter and Full-Year 2005
January 25, 2006: Baxter Receives Marketing Authorization from the European Commission for KIOVIG to Treat Immunodeficiencies
January 25, 2006: Baxter Mourns Passing of William B. Graham, Pioneer and Long-Time Leader in Healthcare
January 17, 2006: California's Venice Family Clinic Wins Prestigious Foster G. McGaw Prize for Excellence in Community Service
January 09, 2006: Baxter Expands BioSurgery Product Portfolio with FDA 510(K) Marketing Clearance for TricOs™ T Bone Void Filler
|
Print this page
